Literature DB >> 19160527

A new type of tripropeptin with anteiso-branched chain fatty acid from Lysobacter sp. BMK333-48F3.

Hideki Hashizume1, Masayuki Igarashi, Ryuichi Sawa, Hayamitsu Adachi, Yoshio Nishimura, Yuzuru Akamatsu.   

Abstract

Branched chain amino acids are often utilized as the precursors of many lipid-containing bacterial secondary metabolites. The effect of isoleucine on the composition of the mixture of cyclic lipopeptide antibiotics, tripropeptins from Lysobacter sp. BMK333-48F3 was evaluated. As expected, a novel tripropeptin analog with an anteiso-branched fatty acid was produced. The new compound, TPPaiC shows potent antibacterial activity against Gram-positive bacteria including MRSA and VRE. On the other hand, no increase was observed in the production of other tripropeptins by the addition of isoleucine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19160527     DOI: 10.1038/ja.2008.78

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  5 in total

Review 1.  Bioactive natural products from Lysobacter.

Authors:  Yunxuan Xie; Stephen Wright; Yuemao Shen; Liangcheng Du
Journal:  Nat Prod Rep       Date:  2012-11       Impact factor: 13.423

2.  Complete genome sequence and expression profile of the commercial lytic enzyme producer Lysobacter enzymogenes M497-1.

Authors:  Hideto Takami; Atsushi Toyoda; Ikuo Uchiyama; Takehiko Itoh; Yoshihiro Takaki; Wataru Arai; Shinro Nishi; Mikihiko Kawai; Kazuo Shin-Ya; Haruo Ikeda
Journal:  DNA Res       Date:  2017-04-01       Impact factor: 4.458

3.  Genome Sequence of Lysobacter sp. Strain BMK333-48F3, the Producer Strain of Potent Lipopeptide Antibiotics of the Tripropeptin Family.

Authors:  Patricia Arlt; Hideki Hashizume; Masayuki Igarashi; Harald Gross
Journal:  Microbiol Resour Announc       Date:  2021-12-09

4.  Antibacterial activity of extracellular compounds produced by a Pseudomonas strain against methicillin-resistant Staphylococcus aureus (MRSA) strains.

Authors:  Viviane F Cardozo; Admilton G Oliveira; Erick K Nishio; Marcia R E Perugini; Célia G T J Andrade; Wanderley D Silveira; Nelson Durán; Galdino Andrade; Renata K T Kobayashi; Gerson Nakazato
Journal:  Ann Clin Microbiol Antimicrob       Date:  2013-06-17       Impact factor: 3.944

5.  Comparative genomics and metabolic profiling of the genus Lysobacter.

Authors:  Irene de Bruijn; Xu Cheng; Victor de Jager; Ruth Gómez Expósito; Jeramie Watrous; Nrupali Patel; Joeke Postma; Pieter C Dorrestein; Donald Kobayashi; Jos M Raaijmakers
Journal:  BMC Genomics       Date:  2015-11-23       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.